K133466 is an FDA 510(k) clearance for the CELLVIZIO 100 SERIES SYSTEM WITH CONFOCAL MINIPROBES (TM). This device is classified as a Confocal Optical Imaging (Class II - Special Controls, product code OWN).
Submitted by Mauna Kea Technologies (Orinda, US). The FDA issued a Cleared decision on July 25, 2014, 255 days after receiving the submission on November 12, 2013.
This device falls under the General & Plastic Surgery FDA review panel. Regulated under 21 CFR 876.1500. Collection Of Light Signals For Visualization Of Cellular Microstructures..